JP2003508513A5 - - Google Patents

Download PDF

Info

Publication number
JP2003508513A5
JP2003508513A5 JP2001521701A JP2001521701A JP2003508513A5 JP 2003508513 A5 JP2003508513 A5 JP 2003508513A5 JP 2001521701 A JP2001521701 A JP 2001521701A JP 2001521701 A JP2001521701 A JP 2001521701A JP 2003508513 A5 JP2003508513 A5 JP 2003508513A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
hydrogen
substituted
methoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001521701A
Other languages
English (en)
Japanese (ja)
Other versions
JP4768941B2 (ja
JP2003508513A (ja
Filing date
Publication date
Priority claimed from DE19941764A external-priority patent/DE19941764A1/de
Application filed filed Critical
Publication of JP2003508513A publication Critical patent/JP2003508513A/ja
Publication of JP2003508513A5 publication Critical patent/JP2003508513A5/ja
Application granted granted Critical
Publication of JP4768941B2 publication Critical patent/JP4768941B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001521701A 1999-09-02 2000-08-17 胆汁酸置換フェニルアルケノイルグアニジン、それらの製造方法、医薬または診断薬としてのそれらの使用、およびそれらを含む医薬 Expired - Fee Related JP4768941B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19941764.4 1999-09-02
DE19941764A DE19941764A1 (de) 1999-09-02 1999-09-02 Substituierte Acylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamente oder Diagnostika sowie sie enthaltende Medikamente
PCT/EP2000/008025 WO2001017954A1 (de) 1999-09-02 2000-08-17 Gallensäure-substituierte phenyl-alkenoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikamente oder diagnostika sowie sie enthaltende medikamente

Publications (3)

Publication Number Publication Date
JP2003508513A JP2003508513A (ja) 2003-03-04
JP2003508513A5 true JP2003508513A5 (cg-RX-API-DMAC7.html) 2007-10-11
JP4768941B2 JP4768941B2 (ja) 2011-09-07

Family

ID=7920512

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001521701A Expired - Fee Related JP4768941B2 (ja) 1999-09-02 2000-08-17 胆汁酸置換フェニルアルケノイルグアニジン、それらの製造方法、医薬または診断薬としてのそれらの使用、およびそれらを含む医薬

Country Status (11)

Country Link
US (1) US6451781B1 (cg-RX-API-DMAC7.html)
EP (1) EP1248768B1 (cg-RX-API-DMAC7.html)
JP (1) JP4768941B2 (cg-RX-API-DMAC7.html)
AT (1) ATE309981T1 (cg-RX-API-DMAC7.html)
AU (1) AU774083B2 (cg-RX-API-DMAC7.html)
CA (1) CA2383729A1 (cg-RX-API-DMAC7.html)
DE (2) DE19941764A1 (cg-RX-API-DMAC7.html)
DK (1) DK1248768T3 (cg-RX-API-DMAC7.html)
ES (1) ES2251403T3 (cg-RX-API-DMAC7.html)
IL (1) IL148250A0 (cg-RX-API-DMAC7.html)
WO (1) WO2001017954A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ563604A (en) * 2001-11-29 2009-04-30 Theracos Inc Compounds for treatment of inflammation, diabetes and related disorders
WO2018129556A1 (en) * 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US10543207B2 (en) 2008-12-31 2020-01-28 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
CN103819403B (zh) * 2008-12-31 2017-01-04 阿德利克斯公司 用于治疗与体液潴留或盐超负荷有关的病症和胃肠道病症的化合物和方法
MX363056B (es) * 2012-08-21 2019-03-06 Ardelyx Inc Compuestos y metodos para inhibir al antipuerto mediado por nhe en el tratamiento de trastornos asociados con la retencion de fluidos o la sobrecarga de sal y trastornos del tracto gastrointestinal.
CN105392483B (zh) 2013-04-12 2019-03-15 阿德利克斯公司 用于抑制磷酸盐转运的nhe3结合化合物和方法
EA201991676A1 (ru) 2017-01-09 2020-01-30 Арделикс, Инк. Ингибиторы nhe-опосредованного антипорта
KR20240090875A (ko) 2017-01-09 2024-06-21 알데릭스, 인코포레이티드 위장관 장애를 치료하는 데 유용한 화합물
US12186329B2 (en) 2018-08-23 2025-01-07 President And Fellows Of Harvard College Compositions and methods related to cholic acid 7-sulfate as a treatment for diabetes
WO2020117945A1 (en) 2018-12-04 2020-06-11 President And Fellows Of Harvard College Synthetic derivatives of cholic acid 7-sulfate and uses thereof
CN120757601A (zh) 2019-05-10 2025-10-10 哈佛大学的校长及成员们 肠道细菌胆汁酸代谢的小分子调节剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0667846B2 (ja) * 1989-04-28 1994-08-31 一 滝川 利胆剤
TW289021B (cg-RX-API-DMAC7.html) 1993-05-08 1996-10-21 Hoechst Ag
IT1274000B (it) * 1994-04-06 1997-07-14 Alfa Wassermann Spa Derivati di acidi biliari utili nella terapia della calcolosi biliare da colesterolo e nelle patologie indotte da colestasi
JPH09315979A (ja) * 1996-05-24 1997-12-09 Tokyo Tanabe Co Ltd 利胆剤
DE19849722A1 (de) * 1998-10-28 2000-05-04 Aventis Pharma Gmbh Substituierte Phenyl-alkenoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Similar Documents

Publication Publication Date Title
RU2003101319A (ru) Фармацевтическая композиция, обладающая улучшенным противоопухолевым действием и/или сниженными побочными эффектами, содержащая противоопухолевый агент и производное гидроксамовой кислоты
EP0352218B1 (de) 5- oder 6-Ring-enthaltende makrocyclische Polyaza-Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
KR102703336B1 (ko) 다이머 조영제
RU2000102359A (ru) Фармацевтическая композиция, обладающая улучшенным противораковым действием и/или сниженными побочными эффектами, содержащая противораковый агент и производное гидроксамовой кислоты
NO2010023I2 (no) Vernakalant eller et solvat eller farmasøytisk akseptabelt salt derav, herunder inkludert vernakalanthydroklorid
JP2001525359A5 (cg-RX-API-DMAC7.html)
CA2404464A1 (en) Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders
DE3809671A1 (de) Porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DK0661259T3 (da) Substituerede (5,6)-dihydronaphthalenylforbindelser med retinoidlignende aktivitet
RU2000113729A (ru) Гетероциклические соединения для ингибирования секреции желудочной кислоты, способы их получения и их фармацевтические компоозиции
JP2005511531A5 (cg-RX-API-DMAC7.html)
JP2004517098A5 (cg-RX-API-DMAC7.html)
JP2001510843A5 (cg-RX-API-DMAC7.html)
JP2012513390A5 (cg-RX-API-DMAC7.html)
KR20230083291A (ko) 암 치료를 위한 병용 요법
WO2017178301A1 (en) Contrast agents
JP2002528460A5 (cg-RX-API-DMAC7.html)
DE60022095T2 (de) Camptothecin-beta-alanin-ester mit topoisomerase i hemmung
EP0994884B1 (en) Diphosphonic acid salts for the treatment of osteoporosis
PT89082B (pt) Processo para a preparacao de novos derivados n-(23-vinblastinoilicos) do acido 1-amino-metilfosfonico
RU2002110440A (ru) Конъюгаты 4-бензиламинохинолинов с желчной кислотой и их гетероаналоги, способы их получения, содержащие эти соединения лекарственные средства и их применение
JP2007525527A5 (cg-RX-API-DMAC7.html)
ATE41659T1 (de) Benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
IL148250A0 (en) Bile acid-substituted phenyl-alkenoylguanidines, method for producing said phenyl-alkenoylguanidines, use thereof as medicaments or diagnostic reagents and medicaments containing the same
US5616312A (en) Thiol ligands and complexes for X-ray imaging